VKH
BLFS icon

Virtu KCG Holdings’s BioLife Solutions BLFS Stock Holding History

Virtu KCG Holdings’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28,864
Closed -$60K – 2900
2017
Q1 		$60K Buy
+28,864
New +$55.9K ﹤0.01% 2801
2016
Q4 		– Sell
-11,639
Closed -$21K – 3398
2016
Q3 		$21K Buy
+11,639
New +$22.1K ﹤0.01% 2915
2015
Q2 		– Sell
-42,674
Closed -$69K – 3331
2015
Q1 		$69K Buy
42,674
+15,458
+57% +$28.9K ﹤0.01% 2747
2014
Q4 		$45K Buy
+27,216
New +$55.9K ﹤0.01% 3465

Other funds holding BLFS

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
CB
Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Virtu KCG Holdings's BLFS Position: Q2 2017 in Review

Virtu KCG Holdings sold out of BioLife Solutions (BLFS) in Q2 2017, closing a stake of 28,864 shares — an estimated $60K sold.

Virtu KCG Holdings first reported a position in BLFS in Q4 2014 and held it in 4 quarters. The position peaked at $69K in Q1 2015. 15 funds tracked by Wall St. Rank hold BLFS as of Q2 2017.

  • Virtu KCG Holdings reported no remaining BioLife Solutions position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 28,864 BioLife Solutions shares in Q2 2017, an estimated $60K.
  • Virtu KCG Holdings first reported a position in BioLife Solutions in Q4 2014 and held it in 4 quarters.
  • Virtu KCG Holdings's BioLife Solutions position peaked at $69K in Q1 2015.
  • 15 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.